Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) saw a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 3,900 shares, ...

The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What Are ...

Biotech stocks may be primed for a long-term bull run. Learn why IBB, XBI, and macro trends like rate cuts make biotech an attractive sector now.

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. The ETF industry ...

VanEck Biotech ETF Trading Up 0.1 % BBH opened at $161.90 on Thursday. VanEck Biotech ETF has a twelve month low of $151.35 and a twelve month high of $183.64. The firm has a market capitalization ...

Stifel Financial was ordered by a Financial Industry Regulatory Authority arbitration panel to pay a family $132.5 million ...

"The reality is, for the biotech industry, while research is the ... and leaders across sectors and in the ETF space. For more expert insight and the latest market action, click here&nbsp ...

VanEck Biotech ETF earns a Below Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical efficacy of passive ...

Major industry benchmarks SPDR S&P Biotech ETF (NYSEARCA:XBI) and the iShares Biotechnology ETF (NASDAQ:IBB) have both trailed the S&P 500 (SP500) over the past 12 months. Operating in an industry ...